REPOS PHARMA AB has a total of 11 patent applications. It increased the IP activity by 350.0%. Its first patent ever was published in 2017. It filed its patents most often in United Kingdom, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals are HEART METABOLICS LTD, VELOCE BIOPHARMA LLC and FORTE IQ B V.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 2 | |
#2 | WIPO (World Intellectual Property Organization) | 2 | |
#3 | Australia | 1 | |
#4 | Brazil | 1 | |
#5 | Canada | 1 | |
#6 | China | 1 | |
#7 | EPO (European Patent Office) | 1 | |
#8 | Republic of Korea | 1 | |
#9 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Nygren Peter | 8 |
#2 | Larsson Rolf | 8 |
#3 | Fryknäs Mårten | 4 |
#4 | Fryknas Marten | 3 |
#5 | Peter Nygren | 2 |
#6 | Marten Fryknäs | 1 |
#7 | Rolf Larsson | 1 |
#8 | Fryknaes Marten | 1 |
Publication | Filing date | Title |
---|---|---|
GB201721287D0 | Treatment for inflammatory disease | |
GB201713852D0 | Cancer treatment |